|
- Metastatic Cancer: When Cancer Spreads - NCI
Metastatic cancer is cancer that spreads from its site of origin to another part of the body Learn how cancer spreads, possible symptoms, common sites where cancer spreads, and how to find out about treatment options
- Definition of metastasis - NCI Dictionary of Cancer Terms
In metastasis, cancer cells break away from where they first formed (primary cancer), travel through the blood or lymph system, and form new tumors (metastatic tumors) in other parts of the body
- Triple-Negative Breast Cancer Clinical Trials - NCI
Enzalutamide, Enzalutamide with Mifepristone, and Treatment of Physician's Choice for the Treatment of Patients with AR-Positive Metastatic Triple-Negative or ER-Low Breast Cancer
- Enzalutamide–Talazoparib Combo for Advanced Prostate Cancer
For men with metastatic castration-resistant prostate cancer, an initial treatment that combines enzalutamide (Xtandi) and talazoparib (Talzenna) may help them live longer than just getting enzalutamide alone, according to updated results from a large clinical trial
- Stomach Cancer Survival Rates and Statistics - NCI
7% for metastatic stomach cancer (cancer has spread beyond the stomach to a distant part of the body) Understanding survival rate statistics Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to you
- Colorectal Cancer Clinical Trials - NCI
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers Status: Active
- Bladder Cancer Prognosis and Survival Rates - NCI
71% for localized bladder cancer (cancer is in the bladder only) 39% for regional bladder cancer (cancer has spread beyond the bladder to nearby lymph nodes or organs) 8% for metastatic bladder cancer (cancer has spread beyond the bladder to a distant part of the body)
- Female Breast Cancer Subtypes — Cancer Stat Facts
Cancer Statistical Fact Sheets are summaries of common cancer types developed to provide an overview of frequently-requested cancer statistics including incidence, mortality, survival, stage, prevalence, and lifetime risk
|
|
|